lifestyle.celebhomes.net

Author: Krystal Biotech, Inc.

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

May 7, 2026
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

May 4, 2026
Krystal Biotech to Present at Upcoming Scientific Conferences

April 30, 2026
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026

April 21, 2026
Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer

February 10, 2026